137
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Translation, Cultural Adaptation, and Validation of the Cantonese Version of SarQoL in Hong Kong’s Older Population: An Interviewer-Administered Questionnaire for Assessing Sarcopenia-Specific Quality of Life in Fieldwork Practice

ORCID Icon, , ORCID Icon, , , , , , , , ORCID Icon & ORCID Icon show all
Pages 1851-1861 | Received 11 Aug 2023, Accepted 10 Oct 2023, Published online: 08 Nov 2023

References

  • Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755–763. doi:10.1093/oxfordjournals.aje.a009520
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq034
  • Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–2646. doi:10.1016/S0140-6736(19)31138-9
  • Yeung SSY, Reijnierse EM, Pham VK, et al. Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta‐analysis. J Cachexia Sarcopenia Muscle. 2019;10(3):485–500. doi:10.1002/jcsm.12411
  • Cawthon PM, Fox KM, Gandra SR, et al. Do muscle mass, muscle density, strength, and physical function similarly influence risk of hospitalization in older adults? J Am Geriatr Soc. 2009;57(8):1411–1419. doi:10.1111/j.1532-5415.2009.02366.x
  • Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population‐based sample of community‐dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290–298. doi:10.1002/jcsm.12073
  • Liu P, Hao Q, Hai S, Wang H, Cao L, Dong B. Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: a systematic review and meta-analysis. Maturitas. 2017;103:16–22. doi:10.1016/j.maturitas.2017.04.007
  • Syddall HE, Martin HJ, Harwood RH, Cooper C, Sayer AA. The SF-36: a simple, effective measure of mobility-disability for epidemiological studies. J Nutr Health Aging. 2009;13:57–62. doi:10.1007/s12603-009-0010-4
  • Rabin R, De Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–343. doi:10.3109/07853890109002087
  • Silva Neto LS, Karnikowiski MG, Tavares AB, Lima RM. Association between sarcopenia, sarcopenic obesity, muscle strength and quality of life variables in elderly women. Braz J Phys Ther. 2012;16:360–367. doi:10.1590/S1413-35552012005000044
  • Yadav A, Chang YH, Carpenter S, et al. Relationship between sarcopenia, six‐minute walk distance and health‐related quality of life in liver transplant candidates. Clin Transplant. 2015;29(2):134–141. doi:10.1111/ctr.12493
  • Beaudart C, Reginster JY, Petermans J, et al. Quality of life and physical components linked to sarcopenia: the SarcoPhAge study. Exp Gerontol. 2015;69:103–110. doi:10.1016/j.exger.2015.05.003
  • Morishita S, Kaida K, Tanaka T, et al. Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. Support Care Cancer. 2012;20:3161–3168. doi:10.1007/s00520-012-1460-5
  • Beaudart C, Biver E, Reginster JY, et al. Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing. 2015;44(6):960–966. doi:10.1093/ageing/afv133
  • Tsekoura M, Billis E, Tsepis E, et al. The effects of group and home-based exercise programs in elderly with sarcopenia: a randomized controlled trial. J Clin Med. 2018;7(12):480. doi:10.3390/jcm7120480
  • Dupont J, Wauters E, Dedenye L et al. Are dietary intake and nutritional status of specific polyunsaturated fatty acids correlated with sarcopenia outcomes in community-dwelling older adults with sarcopenia? - Exploratory results from ENHANce. BMC Geriatrics. 2023, ;23 1 :272. doi:10.1186/s12877-023-04007-9
  • SarQoL. Sarcopenia quality of life. Available from: https://www.sarqol.org/. Accessed June 2, 2023.
  • Beaudart C, Biver E, Reginster JY, et al. Validation of the SarQoL®, a specific health‐related quality of life questionnaire for Sarcopenia. J Cachexia Sarcopenia Muscle. 2017;8(2):238–244. doi:10.1002/jcsm.12149
  • Yu R, Wong M, Leung J, Lee J, Auyeung TW, Woo J. Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults. Geriatr Gerontol Int. 2014;14:15–28.
  • Cheng KY, Chow SK, Hung VW et al, et al. Diagnosis of sarcopenia by evaluating skeletal muscle mass by adjusted bioimpedance analysis validated with dual-energy X-ray absorptiometry. J Cachexia Sarcopenia Muscle. 2021;12(6):2163–2173. doi:10.1002/jcsm.12825
  • Zhu LY, Chan R, Kwok T, Cheng KCC, Ha A, Woo J. Effects of exercise and nutrition supplementation in community-dwelling older Chinese people with sarcopenia: a randomized controlled trial. Age Ageing. 2019;48(2):220–228. doi:10.1093/ageing/afy179
  • Le X, Wei Y, Hao D, et al. Psychometric properties of the Chinese version of the sarcopenia and quality of life, a quality of life questionnaire specific for sarcopenia. Calcif Tissue Int. 2021;109(4):415–422. doi:10.1007/s00223-021-00859-8
  • Lee SC, Chang CF, Wang JY, Liang PJ. Translation and validation of the Taiwanese SarQoL, a quality of life questionnaire specific to sarcopenia. J Formos Med Assoc. 2023;122(3):249–257. doi:10.1016/j.jfma.2022.09.012
  • Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307. e302. doi:10.1016/j.jamda.2019.12.012
  • Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297–334. doi:10.1007/BF02310555
  • DeVellis RF, Thorpe CT. Scale Development: Theory and Applications. 2nd ed. California: Sage Publications Inc; 1991.
  • Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York: McGraw-Hill Inc; 1994.
  • Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi:10.1016/j.jclinepi.2006.03.012
  • Wong ELY, Ramos-Goni JM, Cheung AWL, Wong AYK, Rivero-Arias O. Assessing the use of a feedback module to model EQ-5D-5L health states values in Hong Kong. Patient. 2018;11:235–247. doi:10.1007/s40271-017-0278-0
  • Beaudart C, Edwards M, Moss C, et al. English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia. Age Ageing. 2017;46(2):271–276. doi:10.1093/ageing/afw192
  • Geerinck A, Scheppers A, Beaudart C, et al. Translation and validation of the Dutch SarQoL®, a quality of life questionnaire specific to sarcopenia. J Musculoskelet Neuronal Interact. 2018;18(4):463.
  • Chang KV, Hsu TH, Wu WT, Huang KC, Han DS. Is sarcopenia associated with depression? A systematic review and meta-analysis of observational studies. Age Ageing. 2017;46(5):738–746. doi:10.1093/ageing/afx094
  • Wu X, Li X, Xu M, Zhang Z, He L, Li Y. Sarcopenia prevalence and associated factors among older Chinese population: findings from the China Health and Retirement Longitudinal Study. PLoS One. 2021;16(3):e0247617. doi:10.1371/journal.pone.0247617
  • Petermann‐Rocha F, Balntzi V, Gray SR, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):86–99. doi:10.1002/jcsm.12783